Loading
January 10, 2024 admin

Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023

Now in its seventh year, Acquisition International’s M&A Awards recognizes the excellence of top executives, analysts, investors, and professionals in the M&A sector across diverse industries. In the healthcare domain, Juniper Biologics stands out for the second consecutive year, this time for its acquisition of Caris Molecular Intelligence®, a tumour profiling service for Asia. Juniper Biologics […]

All rights reserved — 2025 © Cypress Pharmaceutical Group

Also add this if smooth scroll is laggy